Apexigen (APGN) Short Interest Ratio & Short Volume → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free APGN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Apexigen Short Interest DataCurrent Short Volume64,500 sharesPrevious Short Volume79,400 sharesChange Vs. Previous Month-18.77%Dollar Volume Sold Short$27,735.00Short Interest Ratio / Days to Cover0.3Last Record DateJuly 31, 2023Outstanding Shares24,862,000 sharesFloat Size21,460,000 sharesShort Percent of Float0.30%Today's Trading Volume0 sharesAverage Trading Volume967,731 sharesToday's Volume Vs. Average0% Short Selling Apexigen ? Sign up to receive the latest short interest report for Apexigen and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAPGN Short Interest Over TimeAPGN Days to Cover Over TimeAPGN Percentage of Float Shorted Over Time Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. Apexigen Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/202364,500 shares $27,735.00 -18.8%0.3%0.3 $0.43 7/15/202379,400 shares $36,444.60 -24.7%0.4%0.3 $0.46 6/30/2023105,400 shares $45,300.92 +19.9%0.5%0.4 $0.43 6/15/202387,900 shares $43,167.69 -64.8%0.4%0.3 $0.49 5/31/2023249,900 shares $133,896.42 +229.7%1.2%0.9 $0.54 5/15/202375,800 shares $25,772.00 No Change0.4%0.6 $0.34 APGN Short Interest - Frequently Asked Questions What is Apexigen's current short interest? Short interest is the volume of Apexigen shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 64,500 shares of APGN short. 0.30% of Apexigen's shares are currently sold short. Learn More on Apexigen's current short interest. What is a good short interest percentage for Apexigen? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.30% of Apexigen's floating shares are currently sold short. Is Apexigen's short interest increasing or decreasing? Apexigen saw a decline in short interest in the month of July. As of July 31st, there was short interest totaling 64,500 shares, a decline of 18.8% from the previous total of 79,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Apexigen's float size? Apexigen currently has issued a total of 24,862,000 shares. Some of Apexigen's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Apexigen currently has a public float of 21,460,000 shares. How does Apexigen's short interest compare to its competitors? 0.30% of Apexigen's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Apexigen: Moleculin Biotech, Inc. (1.24%), Aeterna Zentaris Inc. (0.35%), Akari Therapeutics, Plc (0.01%), Alterity Therapeutics Limited (1.09%), Elevai Labs, Inc. (0.32%), Guardion Health Sciences, Inc. (14.39%), Galera Therapeutics, Inc. (6.52%), NuCana plc (0.50%), Cyclerion Therapeutics, Inc. (1.03%), Virios Therapeutics, Inc. (1.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.34 billion), Occidental Petroleum Co. ($2.88 billion), Coinbase Global, Inc. ($2.50 billion), Rivian Automotive, Inc. ($2.47 billion), Palantir Technologies Inc. ($2.37 billion), Royal Caribbean Cruises Ltd. ($2.33 billion), T. Rowe Price Group, Inc. ($2.29 billion), Tractor Supply ($1.59 billion), Upstart Holdings, Inc. ($1.58 billion), and Enphase Energy, Inc. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Apexigen stock? Short selling APGN is an investing strategy that aims to generate trading profit from Apexigen as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Apexigen? A short squeeze for Apexigen occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APGN, which in turn drives the price of the stock up even further. How often is Apexigen's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APGN, twice per month. The most recent reporting period available is July, 31 2023. More Short Interest Resources from MarketBeat Related Companies: Moleculin Biotech Short Interest Data Aeterna Zentaris Short Interest Data Akari Therapeutics Short Interest Data Alterity Therapeutics Short Interest Data Elevai Labs Short Interest Data Guardion Health Sciences Short Interest Data Galera Therapeutics Short Interest Data NuCana Short Interest Data Cyclerion Therapeutics Short Interest Data Virios Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:APGN) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsMan Who Predicted 2008: “This Will be Worse.”Altimetry